We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+0.34%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$115B
AUM Growth
+$9.78B
Cap. Flow
+$5.11B
Cap. Flow %
4.43%
Top 10 Hldgs %
14.64%
Holding
9,571
New
1,066
Increased
4,008
Reduced
3,386
Closed
872

Sector Composition

Rank Sector Weight
1 Financials 7.82%
2 Industrials 7.49%
3 Consumer Discretionary 7.33%
4 Energy 6.43%
5 Technology 6.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NBSE
8401
PUT
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$5K ﹤0.01%
5
-50
-91% -$53.9K
ONCT
8402
CALL
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$5K ﹤0.01%
3
+2
+200% +$2.84K
ALBO
8403
PUT
DELISTED
Albireo Pharma Inc
ALBO
$5K ﹤0.01%
150
+10
+7% +$336
UMPQ
8404
CALL
DELISTED
Umpqua Holdings Corp
UMPQ
$5K ﹤0.01%
300
CVG
8405
CALL
DELISTED
Convergys
CVG
$5K ﹤0.01%
200
-2,400
-92% -$58.1K
PRKR
8406
DELISTED
Parkervision Inc
PRKR
$5K ﹤0.01%
1,238
+234
+23% +$1.29K
FCRE
8407
CALL
DELISTED
FC Global Realty Incorporated Common Stock
FCRE
$5K ﹤0.01%
+800
New +$7.26K
ERN
8408
PUT
DELISTED
Erin Energy Corp
ERN
$5K ﹤0.01%
+1,200
New +$6.68K
XXIA
8409
PUT
DELISTED
Ixia
XXIA
$5K ﹤0.01%
+400
New +$4.99K
TPI
8410
DELISTED
TIANYIN PHARMACEUTICAL
TPI
$5K ﹤0.01%
11,799
-29,389
-71% -$13.4K
RBY
8411
PUT
DELISTED
RUBICON MENERALS CORP (F)
RBY
$5K ﹤0.01%
+5,000
New +$5.39K
WHZ
8412
CALL
DELISTED
WHITING USA TR II TR UNIT (DE)
WHZ
$5K ﹤0.01%
1,900
-8,600
-82% -$37.5K
VRNG
8413
CALL
DELISTED
VRINGO, INC COM STK NEW (DE)
VRNG
$5K ﹤0.01%
900
-1,090
-55% -$7.08K
IMUC
8414
DELISTED
ImmunoCellular Therapeutics, Ltd.
IMUC
$5K ﹤0.01%
+290
New +$5.58K
AZPN
8415
DELISTED
ASPEN TECHNOLOGY INC
AZPN
$5K ﹤0.01%
109
-78,999
-100% -$3.62M
BDC icon
8416
Belden
BDC
$5.34B
$4K ﹤0.01%
54
-6
-10% -$526
CSR
8417
CALL
Centerspace
CSR
$927M
$4K ﹤0.01%
50
-70
-58% -$5.07K
FN icon
8418
CALL
Fabrinet
FN
$18.9B
$4K ﹤0.01%
200
-3,500
-95% -$66.1K
GALT icon
8419
CALL
Galectin Therapeutics
GALT
$313M
$4K ﹤0.01%
+1,300
New +$3.92K
BRSL
8420
PUT
Brightstar Lottery PLC
BRSL
$2.05B
$4K ﹤0.01%
200
-3,600
-95% -$68.6K
LSTA icon
8421
Lisata Therapeutics
LSTA
$10.3M
$4K ﹤0.01%
+15
New +$5.57K
QSR icon
8422
PUT
Restaurant Brands International
QSR
$25.6B
$4K ﹤0.01%
100
-24,000
-100% -$946K
RIGL icon
8423
CALL
Rigel Pharmaceuticals
RIGL
$780M
$4K ﹤0.01%
+140
New +$5.35K
FLNA
8424
PUT
Filana Therapeutics
FLNA
$47.8M
$4K ﹤0.01%
+300
New +$4.11K
SVM
8425
CALL
Silvercorp Metals
SVM
$2.73B
$4K ﹤0.01%
3,600
+500
+16% +$602

Similar funds

Citadel Advisors's Q2 2015 Portfolio in Review

As of Q2 2015, Citadel Advisors held 9,571 positions worth $115B, up 9.3% from $106B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Citadel Advisors deployed $5.11B of net new capital in Q2 2015, opening 1,066 new positions and adding to 4,008 existing holdings. Its largest new stake was Macy's: 3,207,474 shares worth $216M.

By sector, the portfolio is most concentrated in Financials at 7.8% of assets, up from 7.7% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Dollar General, an estimated $323M trimmed.

  • Citadel Advisors's largest Q2 2015 buy was Macy's: 3,207,474 shares worth $216M.
  • Citadel Advisors added most to Chubb in Q2 2015, an estimated $457M increase.
  • Citadel Advisors's biggest Q2 2015 reduction was Dollar General, cutting an estimated $323M.
  • Citadel Advisors fully exited Citizens Financial Group in Q2 2015, selling an estimated $280M.
  • Citadel Advisors's ten largest holdings make up 15% of its $115B portfolio in Q2 2015.
  • Citadel Advisors opened 1,066 new positions and closed 872 in Q2 2015.
  • Citadel Advisors's portfolio value rose 9.3% quarter-over-quarter to $115B.

Based on Citadel Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.